HMGA2 and ovarian carcinoma: In this study, we report that INAVA mRNA is selectively enriched in EVs derived from ovarian cancer cells, which promotes the progression of ovarian cancer cells by activating normal ovarian fibroblasts (NOFs) in the TME via the HMGA2‐TRIM21‐STAT3 axis.